Compare FTH & GCGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTH | GCGR |
|---|---|---|
| Founded | 1999 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.8M | 467.9M |
| IPO Year | 2021 | 2026 |
| Metric | FTH | GCGR |
|---|---|---|
| Price | $21.84 | $10.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $55.31 | N/A |
| AVG Volume (30 Days) | ★ 351.3K | 107.1K |
| Earning Date | 11-03-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.57 | $9.95 |
| 52 Week High | $42.14 | $10.20 |
| Indicator | FTH | GCGR |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 47.13 |
| Support Level | $16.57 | $9.95 |
| Resistance Level | $21.97 | $10.12 |
| Average True Range (ATR) | 2.02 | 0.03 |
| MACD | 0.65 | 0.00 |
| Stochastic Oscillator | 87.41 | 47.37 |
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
General Catalyst Global Resilience Merger Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.